| scholarly article | Q13442814 |
| P2093 | author name string | Jennifer R Havens | |
| Dustin B Stephens | |||
| P2860 | cites work | Epidemiology of hepatitis C virus infection | Q22305500 |
| Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews | Q24630669 | ||
| Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users | Q27488233 | ||
| Ethanol Enhances Hepatitis C Virus Replication through Lipid Metabolism and Elevated NADH/NAD+ | Q27490772 | ||
| Impact of alcohol on hepatitis C virus replication and interferon signaling | Q27491301 | ||
| Global epidemiology of hepatitis C virus infection | Q27860799 | ||
| Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study | Q28249485 | ||
| The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study | Q28476680 | ||
| The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome | Q29620780 | ||
| Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco | Q33489194 | ||
| Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection | Q33650138 | ||
| The natural history of hepatitis C virus infection: host, viral, and environmental factors | Q33974693 | ||
| High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities | Q33989662 | ||
| Impact of hepatitis C virus infection on lifestyle | Q34100056 | ||
| Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England | Q34147370 | ||
| Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions | Q34426901 | ||
| Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention | Q34981603 | ||
| Hepatitis C and alcohol: interactions, outcomes, and implications | Q35067811 | ||
| Natural history of hepatitis C virus infection | Q74095636 | ||
| Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study | Q74527344 | ||
| How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C? | Q74705039 | ||
| NIH Consensus Statement on Management of Hepatitis C: 2002 | Q75442808 | ||
| Self-report among injecting drug users: a review | Q77462275 | ||
| Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms | Q77990991 | ||
| Clinical trial results of peginterferons in combination with ribavirin | Q35204884 | ||
| Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalence | Q35230093 | ||
| Stimulant use trajectories and the longitudinal risk of heavy drinking: findings from a rural population-based study | Q35682288 | ||
| Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. | Q35683199 | ||
| OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users | Q35902396 | ||
| The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan | Q36185899 | ||
| Traveling young injection drug users at high risk for acquisition and transmission of viral infections | Q36468291 | ||
| Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia. | Q36607811 | ||
| Global estimates of prevalence of HCV infection among injecting drug users. | Q36940143 | ||
| Future of hepatitis C therapy: development of direct-acting antivirals | Q37928362 | ||
| Impact of HCV genetic differences on pathobiology of disease. | Q37929753 | ||
| Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences | Q38457050 | ||
| Reliability of drug dependents' self-reports. | Q39446741 | ||
| Interaction of alcohol intake and cofactors on the risk of cirrhosis | Q39494191 | ||
| Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users | Q39755588 | ||
| Respondent-driven sampling in the recruitment of illicit stimulant drug users in a rural setting: findings and technical issues | Q39765276 | ||
| Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users | Q39768011 | ||
| High incidence of hepatitis C virus reinfection within a cohort of injecting drug users | Q39797179 | ||
| Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. | Q39808476 | ||
| Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. | Q39820916 | ||
| High incidence of hepatitis C virus reinfection in a cohort of injecting drug users | Q40037737 | ||
| Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States | Q40300556 | ||
| Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. | Q41135943 | ||
| Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study | Q42980911 | ||
| Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population | Q42987726 | ||
| Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. | Q42988446 | ||
| Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam | Q42989819 | ||
| Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study | Q42993513 | ||
| Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland | Q43040032 | ||
| Influence of hepatitis C status on alcohol consumption in opiate users in treatment | Q43664338 | ||
| Impact of medical recommendations on alcohol consumption in HCV positive patients. | Q43753038 | ||
| Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection | Q43993357 | ||
| A randomized trial of a brief alcohol intervention for needle exchangers (BRAINE). | Q44041490 | ||
| The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users | Q44163628 | ||
| Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men. | Q44241343 | ||
| Trajectories of adolescent alcohol and cannabis use into young adulthood | Q44334611 | ||
| Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment | Q44334824 | ||
| Risks of a range of alcohol intake on hepatitis C-related fibrosis | Q44785882 | ||
| The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. | Q44979610 | ||
| Impact of alcohol on the histological and clinical progression of hepatitis C infection. | Q50867355 | ||
| Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. | Q51032655 | ||
| Categorizing substance abusers using the ASI: implications for evaluation and treatment. | Q51720407 | ||
| Antisocial behavioral syndromes and DSM-IV alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. | Q51905409 | ||
| The effect of light drinking on HCV liver disease: the jury is still out. | Q53362965 | ||
| Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users. | Q53516509 | ||
| Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users | Q61098957 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| alcohol consumption | Q2647488 | ||
| P304 | page(s) | 386-395 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Journal of Studies on Alcohol and Drugs | Q6295973 |
| P1476 | title | Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status | |
| P478 | volume | 74 |
| Q31060674 | A Systematic Review of Published Respondent-Driven Sampling Surveys Collecting Behavioral and Biologic Data. |
| Q36733235 | Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy |
| Q38769007 | Examining the social context of injection drug use: social proximity vs. geographic proximity to others who inject drugs |
| Q89624009 | Opioid epidemic and liver disease |
| Q47763779 | The Role of Alcohol on Antiretroviral Therapy Adherence Among Persons Living With HIV in Urban India. |
| Q93346255 | Using Network and Spatial Data to Better Target Overdose Prevention Strategies in Rural Appalachia |
Search more.